October Smashes Merger Records as Companies Turn to Megadeals
(Bloomberg) -- Forget merger Monday: October as a whole was a record month for dealmaking, with almost half a trillion dollars of mergers and acquisitions announced globally.
CenturyLink Inc.'s $34 billion acquisition of Level 3 Communications Inc., as well as General Electric Co.'s deal to combine its oil and gas division with Baker Hughes Inc., pushed October's deal volumes to about $489 billion, according to data compiled by Bloomberg. That's the highest amount for at least 12 years, topping the previous record of $471 billion in April 2007, the data show.
“Every weekend recently has been busy,” Bob Profusek, partner and chair of the global M&A practice at law firm Jones Day, said in an interview Monday on Bloomberg Television.
“The fundamental drivers are still there,” Profusek said. “Low growth -- which is bad for most things, but it's good for M&A because that's how you get growth -- and very accommodating capital markets.”
Profusek worked for Potash Corp. on its merger with Agrium Inc., and is advising Reynolds American Inc. on British American Tobacco Plc's $47 billion bid for the rest of the company.
To watch Bob Profusek talk about oil and gas M&A, click here
More Megadeals
Just eight transactions account for more than $300 billion of the October total as megadeals continue to find favor among dealmakers. The biggest deal of the year, AT&T Inc.'s $85.4 billion bid for Time Warner Inc., was revealed on Oct. 22 in a rare Saturday deal announcement.
So far this year, 32 deals valued at more than $10 billion have been struck. That puts 2016 on track to beat every year since 2007 except for last year, when a bumper 52 transactions of that size or more were announced.
“Size matters,” said Profusek, “particularly because we're in a very challenging regulatory environment right now.”
Almost 30 deals announced since the start of 2015 have not yet closed, including Dow Chemical Co.'s $59 billion merger with DuPont Co., which was pushed back until next year.
The two health insurance megadeals -- Anthem Inc.'s bid for Cigna Corp. and Aetna Inc.'s offer for Humana Inc. -- are also still pending. Both those deals are currently trading with at least $40 gaps between the offer price and the target's current share price, indicating investors are pessimistic they will close.
Despite currency and equity markets reacting skittishly to poll results and news sentiment in the final days before the U.S. presidential election, M&A activity is forging ahead.
“I don't hear boards or management really putting the election high on their list of concerns,” Frank Aquila, partner at law firm Sullivan & Cromwell LLP, said in a telephone interview. “Unless there is some sort of regulatory deadline or tax deadline that people are working to, deals get there when they get there.”
--With assistance from Alex Sherman Alex Barinka and Jeffrey McCracken To contact the reporter on this story: Elizabeth Fournier in London at efournier5@bloomberg.net. To contact the editors responsible for this story: Jeffrey McCracken at jmccracken3@bloomberg.net, Devin Banerjee
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.